Skip to main content

Market Overview

Raymond James: Bed Bath & Beyond Could Be Unbound After Q2 Report

Share:
Raymond James: Bed Bath & Beyond Could Be Unbound After Q2 Report

Like many of its retail peers, Bed Bath & Beyond Inc. (NASDAQ: BBBY) could post a big beat in second-quarter sales, but that won't necessarily read through to better near-term margins, according to Raymond James. 

The Analyst 

Analyst Budd Bugatch upgraded Bed Bath & Beyond from Underperform to Market Perform.

The Thesis

Bugatch said he anticipates outperformance in same-store sales given a better-than-expected retail environment. (See the analyst's track record here.) 

Despite a projected drop in year-over-year earnings, Bed Bath & Beyond's Sept. 26 quarterly print presents a "trading opportunity" — and nothing more specific than that, Bugatch said. 

“Since a bearish rating now seems too harsh and a constructive rating yet too aggressive, we believe a neutral-type rating is now more appropriate for BBBY — at least until we find the path to an operating profit/margin improvement to be more visible,” the analyst said. 

This is better than the retailer's previous condition, which saw trailing-four-quarter consolidated operating margins compress by more than 1,000 basis points.

“The last five years have been very difficult for Bed Bath’s shareholders; and not much fun for company leaders or board members,” Bugatch said. “While management was focused on transforming Bed Bath by building-out its digital/analytical capabilities and by seeking to become ‘trusted by its customers as the expert for the home and heartfelt life events,’ its efforts came at a high cost.”

Now, with Bed Bath & Beyond guiding for near-term comps growth and diminished declines in operating profit, Raymond James predicts a 2020 bottom to the TFQ operating margin.

Price Action

Bed Bath & Beyond shares were up 5.59 percent at $19.08 at the time of publication Monday.

Related Links:

Analyst: Toys R Us Closures Could Be Positive Catalyst For Bed Bath & Beyond

Bed Bath & Beyond Shares Down, Analysts Chilly After Q3 Report

Photo by Raysonho/Wikimedia. 

Latest Ratings for BBBY

DateFirmActionFromTo
Mar 2022Telsey Advisory GroupMaintainsMarket Perform
Jan 2022Goldman SachsMaintainsSell
Jan 2022Telsey Advisory GroupMaintainsMarket Perform

View More Analyst Ratings for BBBY

View the Latest Analyst Ratings

 

Related Articles (BBBY)

View Comments and Join the Discussion!

Posted-In: Budd Bugatch retailAnalyst Color Upgrades Analyst Ratings Best of Benzinga

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com